{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01518166","recordId":"NCT01518166","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01518166-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct01518166.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct01518166.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2012-01-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-01-21","publishedAt":"2026-08-23","recordId":"NCT01518166","recordSha256":"4b7b3845a29d5de5299c29addd685f743d76824cef4bd9f891cb512a26fdb7de","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01518166?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2015-01-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2015-01-29","publishedAt":"2026-08-23","recordId":"NCT01518166","recordSha256":"d3255efa267b4fb5c4901af71253b11dae8e25b3854492061f593eafd322b705","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01518166?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","References","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2017-01-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-01-24","publishedAt":"2026-08-23","recordId":"NCT01518166","recordSha256":"1f25e70d76445c9f14606dacd57d5589550ee95e3528626d9daf1d4daff93db8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01518166?a=3&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"23e1a3e784c3915ae1b18a3b69d4a169a6b417409cefc4b05d1d37762578db5d"}}